These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16328040)

  • 1. Combined modality therapy of gemcitabine and irradiation on human glioma spheroids derived from cell lines and biopsy tissue.
    Fehlauer F; Muench M; Smid EJ; Slotman B; Richter E; Van der Valk P; Sminia P
    Oncol Rep; 2006 Jan; 15(1):97-105. PubMed ID: 16328040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of irradiation and cisplatin on human glioma spheroids: inhibition of cell proliferation and cell migration.
    Fehlauer F; Muench M; Rades D; Stalpers LJ; Leenstra S; van der Valk P; Slotman B; Smid EJ; Sminia P
    J Cancer Res Clin Oncol; 2005 Nov; 131(11):723-32. PubMed ID: 16096850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibition of proliferation and migration of glioma spheroids exposed to temozolomide is less than additive if combined with irradiation.
    Fehlauer F; Muench M; Richter E; Rades D
    Oncol Rep; 2007 Apr; 17(4):941-5. PubMed ID: 17342340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of effects of irradiation by gemcitabine in a glioblastoma cell line and cell line spheroids.
    Genç M; Castro Kreder N; Barten-van Rijbroek A; Stalpers LJ; Haveman J
    J Cancer Res Clin Oncol; 2004 Jan; 130(1):45-51. PubMed ID: 14605880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effects of deuterium oxide and gemcitabine in human pancreatic cancer cell lines.
    Bader Y; Hartmann J; Horvath Z; Saiko P; Grusch M; Madlener S; Maier S; Oehler L; Fritzer-Szekeres M; Heller N; Alken RG; Krupitza G; Szekeres T
    Cancer Lett; 2008 Feb; 259(2):231-9. PubMed ID: 18023527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The radioenhancement of two human head and neck squamous cell carcinomas by 2'-2' difluorodeoxycytidine (gemcitabine; dFdC) is mediated by an increase in radiation-induced residual chromosome aberrations but not residual DNA DSBs.
    Rosier JF; Michaux L; Ameye G; Cedervall B; Libouton JM; Octave-Prignot M; Verellen-Dumoulin C; Scalliet P; Grégoire V
    Mutat Res; 2003 Jun; 527(1-2):15-26. PubMed ID: 12787910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a perinecrotic 60 kDa MDM2 isoform within glioma spheroids and glioblastoma biopsy material.
    Bell HS; Whittle IR; Bader SA; Wharton SB
    Neuropathol Appl Neurobiol; 2005 Apr; 31(2):191-202. PubMed ID: 15771712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanistic study of radiosensitization by gemcitabine on human squamous carcinoma cell line of the cervix].
    Miao JW; Kong WM; Zhang WH; Niu JW; Deng XH
    Zhonghua Fu Chan Ke Za Zhi; 2004 May; 39(5):342-5. PubMed ID: 15196420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential mechanisms of radiosensitization by 2-deoxy-D-glucose in the monolayers and multicellular spheroids of a human glioma cell line.
    Khaitan D; Chandna S; Arya MB; Dwarakanath BS
    Cancer Biol Ther; 2006 Sep; 5(9):1142-51. PubMed ID: 16855378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation enhancement of gemcitabine in two human squamous cell carcinoma cell lines.
    Mose S; Karapetian M; Jüling-Pohlit L; Taborski B; Damrau M; Ramm U; Rahn A; Böttcher HD
    Anticancer Res; 2000; 20(1A):401-5. PubMed ID: 10769687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin augments survival of glioma cells after radiation and temozolomide.
    Hassouna I; Sperling S; Kim E; Schulz-Schaeffer W; Rave-Fränk M; Hasselblatt M; Jelkmann W; Giese A; Ehrenreich H
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):927-34. PubMed ID: 19014782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant increase in residual DNA damage as a possible mechanism of radiosensitization by gemcitabine.
    Weiss C; Grabenbauer GG; Sauer R; Distel L
    Strahlenther Onkol; 2003 Feb; 179(2):93-8. PubMed ID: 12590319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comment on "gemcitabine, PI3kinase-Akt pathway inhibition and radiation in human glioma cell lines" by M.S. Elnaggar et al.
    Balaji MB; Brahma N; Vimal S
    Med Oncol; 2024 Sep; 41(10):248. PubMed ID: 39312103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective targeting of homologous DNA recombination repair by gemcitabine.
    Wachters FM; van Putten JW; Maring JG; Zdzienicka MZ; Groen HJ; Kampinga HH
    Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):553-62. PubMed ID: 12957269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined modality therapy of gemcitabine and radiation.
    Pauwels B; Korst AE; Lardon F; Vermorken JB
    Oncologist; 2005 Jan; 10(1):34-51. PubMed ID: 15632251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferation, migration and invasion of human glioma cells exposed to paclitaxel (Taxol) in vitro.
    Terzis AJ; Thorsen F; Heese O; Visted T; Bjerkvig R; Dahl O; Arnold H; Gundersen G
    Br J Cancer; 1997; 75(12):1744-52. PubMed ID: 9192976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxygenation and response to irradiation of organotypic multicellular spheroids of human glioma.
    Sminia P; Acker H; Eikesdal HP; Kaaijk P; Enger Pø; Slotman B; Bjerkvig R
    Anticancer Res; 2003; 23(2B):1461-6. PubMed ID: 12820410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity to ionizing radiation and chemotherapeutic agents in gemcitabine-resistant human tumor cell lines.
    van Bree C; Castro Kreder N; Loves WJ; Franken NA; Peters GJ; Haveman J
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):237-44. PubMed ID: 12182997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organotypic brain explant culture as a drug evaluation system for malignant brain tumors.
    Minami N; Maeda Y; Shibao S; Arima Y; Ohka F; Kondo Y; Maruyama K; Kusuhara M; Sasayama T; Kohmura E; Saya H; Sampetrean O
    Cancer Med; 2017 Nov; 6(11):2635-2645. PubMed ID: 28980419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemcitabine as a radiosensitizer in undifferentiated tumors.
    Kal HB; El Sharouni SY; Barten-van Rijbroek AD
    Anticancer Res; 2006; 26(1A):139-45. PubMed ID: 16475690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.